» Articles » PMID: 37484617

Use of Artificial Intelligence in Forecasting Glaucoma Progression

Overview
Specialty Ophthalmology
Date 2023 Jul 24
PMID 37484617
Authors
Affiliations
Soon will be listed here.
Abstract

Artificial intelligence (AI) has been widely used in ophthalmology for disease detection and monitoring progression. For glaucoma research, AI has been used to understand progression patterns and forecast disease trajectory based on analysis of clinical and imaging data. Techniques such as machine learning, natural language processing, and deep learning have been employed for this purpose. The results from studies using AI for forecasting glaucoma progression however vary considerably due to dataset constraints, lack of a standard progression definition and differences in methodology and approach. While glaucoma detection and screening have been the focus of most research that has been published in the last few years, in this narrative review we focus on studies that specifically address glaucoma progression. We also summarize the current evidence, highlight studies that have translational potential, and provide suggestions on how future research that addresses glaucoma progression can be improved.

Citing Articles

Deep Learning in Glaucoma Detection and Progression Prediction: A Systematic Review and Meta-Analysis.

Ling X, Chen H, Yeh P, Cheng Y, Huang C, Shen S Biomedicines. 2025; 13(2).

PMID: 40002833 PMC: 11852503. DOI: 10.3390/biomedicines13020420.


Artificial intelligence and big data integration in anterior segment imaging for glaucoma.

Chansangpetch S, Ittarat M, Cheungpasitporn W, Lin S Taiwan J Ophthalmol. 2024; 14(3):319-332.

PMID: 39430364 PMC: 11488806. DOI: 10.4103/tjo.TJO-D-24-00053.


Deep Learning Evaluation of Glaucoma Detection Using Fundus Photographs in Highly Myopic Populations.

Chiang Y, Chen C, Chen Y Biomedicines. 2024; 12(7).

PMID: 39061968 PMC: 11274657. DOI: 10.3390/biomedicines12071394.


The power of big data and artificial intelligence in ophthalmology.

Cheng C Taiwan J Ophthalmol. 2023; 13(2):121-122.

PMID: 37484610 PMC: 10361431. DOI: 10.4103/tjo.TJO-D-23-00069.

References
1.
Lindblom B, Nordmann J, Sellem E, Chen E, Gold R, Polland W . A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden. Acta Ophthalmol Scand. 2006; 84(1):74-83. DOI: 10.1111/j.1600-0420.2005.00560.x. View

2.
Aref A, Budenz D . Detecting Visual Field Progression. Ophthalmology. 2017; 124(12S):S51-S56. DOI: 10.1016/j.ophtha.2017.05.010. View

3.
Shon K, Sung K, Shin J . Can Artificial Intelligence Predict Glaucomatous Visual Field Progression? A Spatial-Ordinal Convolutional Neural Network Model. Am J Ophthalmol. 2021; 233:124-134. DOI: 10.1016/j.ajo.2021.06.025. View

4.
Raja H, Hassan T, Akram M, Werghi N . Clinically Verified Hybrid Deep Learning System for Retinal Ganglion Cells Aware Grading of Glaucomatous Progression. IEEE Trans Biomed Eng. 2020; 68(7):2140-2151. DOI: 10.1109/TBME.2020.3030085. View

5.
Lazaridis G, Lorenzi M, Mohamed-Noriega J, Aguilar-Munoa S, Suzuki K, Nomoto H . OCT Signal Enhancement with Deep Learning. Ophthalmol Glaucoma. 2020; 4(3):295-304. DOI: 10.1016/j.ogla.2020.10.008. View